BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30415900)

  • 1. Structural valve deterioration of bioprosthetic aortic valves: An underestimated complication.
    Sénage T; Gillaizeau F; Le Tourneau T; Marie B; Roussel JC; Foucher Y
    J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1383-1390.e5. PubMed ID: 30415900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fate of aortic bioprostheses: An 18-year experience.
    Piccardo A; Blossier JD; Le Guyader A; Orsel I; Sekkal S; Cornu E; Laskar M
    J Thorac Cardiovasc Surg; 2016 Mar; 151(3):754-761.e1. PubMed ID: 26651959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Long-Term Structural Deterioration of Transcatheter Aortic Bioprosthetic Valves Using the New European Definition.
    Durand E; Sokoloff A; Urena-Alcazar M; Chevalier B; Chassaing S; Didier R; Tron C; Litzler PY; Bouleti C; Himbert D; Hovasse T; Bar O; Avinée G; Iung B; Blanchard D; Gilard M; Cribier A; Lefevre T; Eltchaninoff H
    Circ Cardiovasc Interv; 2019 Apr; 12(4):e007597. PubMed ID: 30998397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early structural valve deterioration of Mitroflow aortic bioprosthesis: mode, incidence, and impact on outcome in a large cohort of patients.
    Sénage T; Le Tourneau T; Foucher Y; Pattier S; Cueff C; Michel M; Serfaty JM; Mugniot A; Périgaud C; Carton HF; Al Habash O; Baron O; Roussel JC
    Circulation; 2014 Dec; 130(23):2012-20. PubMed ID: 25355912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Outcomes After Transcatheter Aortic Valve-in-Valve Replacement.
    de Freitas Campos Guimarães L; Urena M; Wijeysundera HC; Munoz-Garcia A; Serra V; Benitez LM; Auffret V; Cheema AN; Amat-Santos IJ; Fisher Q; Himbert D; Garcia Del Blanco B; Dager A; Le Breton H; Paradis JM; Dumont E; Pibarot P; Rodés-Cabau J
    Circ Cardiovasc Interv; 2018 Sep; 11(9):e007038. PubMed ID: 30354588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of Bioprosthetic Aortic Valve Degeneration.
    Nitsche C; Kammerlander AA; Knechtelsdorfer K; Kraiger JA; Goliasch G; Dona C; Schachner L; Öztürk B; Binder C; Duca F; Aschauer S; Zimpfer D; Bonderman D; Hengstenberg C; Mascherbauer J
    JACC Cardiovasc Imaging; 2020 Feb; 13(2 Pt 1):345-353. PubMed ID: 30878425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early structural valve deterioration and reoperation associated with the mitroflow aortic valve.
    Axtell AL; Chang DC; Melnitchouk S; Jassar AS; Tolis G; Villavicencio MA; Sundt TM; D'Alessandro DA
    J Card Surg; 2018 Dec; 33(12):778-786. PubMed ID: 30525247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valve-in-valve implantation of Medtronic CoreValve prosthesis in patients with failing bioprosthetic aortic valves.
    Linke A; Woitek F; Merx MW; Schiefer C; Möbius-Winkler S; Holzhey D; Rastan A; Ender J; Walther T; Kelm M; Mohr FW; Schuler G
    Circ Cardiovasc Interv; 2012 Oct; 5(5):689-97. PubMed ID: 23048050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitroflow LXA structural deterioration following aortic valve replacement: a single-center experience.
    Zannis K; Diplaris K; Monin JL; Khelil N; Debauchez M; Dervanian P; Lansac E; Czirom D; Noghin M; Mankoubi L; Amabile N
    J Cardiovasc Surg (Torino); 2018 Oct; 59(5):746-752. PubMed ID: 29786406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Durability after aortic valve replacement with the Mitroflow versus the Perimount pericardial bioprosthesis: a single-centre experience in 2393 patients.
    Nielsen PH; Hjortdal V; Modrau IS; Jensen H; Kimose HH; Terp K; Poulsen SH; Smerup M; Nielsen SL
    Eur J Cardiothorac Surg; 2016 Jun; 49(6):1705-10. PubMed ID: 26984983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early calcification of the aortic Mitroflow pericardial bioprosthesis in the elderly.
    Alvarez JR; Sierra J; Vega M; Adrio B; Martinez-Comendador J; Gude F; Martinez-Cereijo J; Garcia J
    Interact Cardiovasc Thorac Surg; 2009 Nov; 9(5):842-6. PubMed ID: 19679611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-prosthesis mismatch in patients undergoing bioprosthetic aortic valve implantation increases risk of reoperation for structural valve deterioration.
    Urso S; Calderón P; Sadaba R; Mahillo I; Tuñón J; Aldamiz G; Fraile J
    J Card Surg; 2014 Jul; 29(4):439-44. PubMed ID: 24773571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results of the Mitroflow aortic pericardial bioprosthesis in over 800 patients: limited durability and mechanisms of dysfunction.
    Ius F; Schulz J; Roumieh M; Fleissner F; Ismail I; Tudorache I; Warnecke G; Martens A; Shrestha M; Boethig D; Haverich A; Cebotari S
    Eur J Cardiothorac Surg; 2017 Aug; 52(2):264-271. PubMed ID: 28838100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of Mitroflow bioprosthesis structural valve deterioration on cardiac morbidity.
    Waziri F; Karunanithi Z; Løgstrup BB; Hjortdal V; Nielsen PH; Poulsen SH
    J Cardiothorac Surg; 2019 Mar; 14(1):62. PubMed ID: 30885227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Durability of the Mitroflow Pericardial Prosthesis: Influence of Patient-Prosthesis Mismatch and New Anticalcification Treatment.
    Blasi S; Ravenni G; Celiento M; De Martino A; Milano AD; Bortolotti U
    Thorac Cardiovasc Surg; 2020 Mar; 68(2):131-140. PubMed ID: 30060268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of the Medtronic Mosaic porcine bioprosthesis in the aortic position.
    Anselmi A; Flécher E; Ruggieri VG; Harmouche M; Langanay T; Corbineau H; Verhoye JP; Leguerrier A
    J Thorac Cardiovasc Surg; 2014 Jun; 147(6):1884-91. PubMed ID: 23988288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Outcomes and Durability of the Mitroflow Aortic Bioprosthesis.
    Mosquera VX; Bouzas-Mosquera A; Velasco-García C; Muñiz J; Estévez-Cid F; Portela-Torron F; Herrera-Noreña JM; Cuenca-Castillo JJ
    J Card Surg; 2016 May; 31(5):264-73. PubMed ID: 26991888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incremental Prognostic Use of Left Ventricular Global Longitudinal Strain in Asymptomatic/Minimally Symptomatic Patients With Severe Bioprosthetic Aortic Stenosis Undergoing Redo Aortic Valve Replacement.
    Naji P; Shah S; Svensson LG; Gillinov AM; Johnston DR; Rodriguez LL; Grimm RA; Griffin BP; Desai MY
    Circ Cardiovasc Imaging; 2017 Jun; 10(6):. PubMed ID: 28559420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcatheter Replacement of Failed Bioprosthetic Valves: Large Multicenter Assessment of the Effect of Implantation Depth on Hemodynamics After Aortic Valve-in-Valve.
    Simonato M; Webb J; Kornowski R; Vahanian A; Frerker C; Nissen H; Bleiziffer S; Duncan A; Rodés-Cabau J; Attizzani GF; Horlick E; Latib A; Bekeredjian R; Barbanti M; Lefevre T; Cerillo A; Hernández JM; Bruschi G; Spargias K; Iadanza A; Brecker S; Palma JH; Finkelstein A; Abdel-Wahab M; Lemos P; Petronio AS; Champagnac D; Sinning JM; Salizzoni S; Napodano M; Fiorina C; Marzocchi A; Leon M; Dvir D
    Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27301396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten-year results of aortic valve replacement with first-generation Mitroflow bioprosthesis: is early degeneration a structural or a technical issue?
    Lootens L; Verbeke J; Martens T; Philipsen T; Caes F; Van Belleghem Y; Van Nooten G; François K; De Bacquer D; Bove T
    Eur J Cardiothorac Surg; 2017 Aug; 52(2):272-278. PubMed ID: 28430883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.